MedPath

Comparison Between the Effect of Nd: YAG Laser and Glucantime on Treatment of Cutaneous Leishmaniasis

Phase 4
Conditions
Cutaneous leishmaniasis.
Cutaneous leishmaniasis
Registration Number
IRCT2017042911363N2
Lead Sponsor
Vice Chancellor for Research of Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Being 5 to 55 years of age; having at least two leishmanial injuries (leishmaniasis is defined as having a clinical injury according to Cutaneous leishmaniasis along with positive smear test regarding leishmanial body confirmed by a pathologist.
Exclusion criteria:Being pregnant or nursing; receiving any prior treatments (including medical or cryotherapy or laser or other destructive methods).

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete improvement of the injury. Timepoint: At the end of every session, 10 weeks after start of treatment, and 3 months after improvement. Method of measurement: Measuring the induration and the size of the injury.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath